| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |